Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Affymax completes enrollment for Phase III anemia trial (Pharmaceutical Business Review) |
Affymax, a biopharmaceutical company, has completed enrollment in Emerald 1, one of its Phase III clinical trials of its lead investigational therapy, Hematide, which is being evaluated for the treatment of anemia in chronic renal failure patients. |